Last reviewed · How we verify
NCT06917235
Wrist and Carpal Arthrodeses. A 1-year Follow-up Study.
trial testing Wrist and carpal arthrodesis in Arthrodesis in 20 participants. Currently enrolling.
15 August 2028
Quick facts
| Lead sponsor | Vestre Viken Hospital Trust |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 1 September 2024 |
| Primary completion | 15 August 2028 |
| Estimated completion | 15 August 2029 |
| Sites | 2 locations across Norway |
Drugs / interventions tested
- Wrist and carpal arthrodesis
Conditions studied
- Arthrodesis — all drugs for Arthrodesis →
- Arthrosis — all drugs for Arthrosis →
- Wrist Osteoarthritis — all drugs for Wrist Osteoarthritis →
Sponsor
Vestre Viken Hospital Trust
Who can join
Eligibility, any sex, with Arthrodesis or Arthrosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study at the Orthopedic Department, Drammen Hospital, examines the effectiveness and safety of various arthrodesis procedures in the wrist and carpus to relieve chronic pain and restore functional stability. Arthrodesis, which fuses two or more bones to eliminate joint mobility, is considered as a last resort when conservative treatments do not produce the desired results. The study includes patients with advanced degenerative changes, rheumatoid arthritis, or extensive injuries. Patients assessed preoperatively and postoperatively through measurements of range of motion, grip strength, and pain using various tools such as PRWHE, QuickDASH, EQ-5D-5L and NRS. The checks include X-rays and CT to evaluate healing. The data is analyzed to identify trends and factors that influence positively outcome. The follow-up takes place after 8 weeks, 3 months and 1 year postoperatively, with a focus on pain relief and functional improvement. The data are compared before and after surgery to assess the effectiveness of the intervention efficiency. The study has been applied for approval by REK, but rejected because it was assessed as a quality control project, and applied for the Data Protection Commissioner (PVO). The data is anonymised and stored on secure servers, with switch keys stored separately. The patients give informed consent and are insured through Norwegian Patient Injury Compensation. The study seeks to improve patient care by increasing understanding of the long-term effects of osteoarthritis, including complications and secondary osteoarthritis. The results will contribute to better clinical decisions and treatments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06917235
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arthrodesis
Currently open trials in the same condition.
- NCT05046600 — Registry of Arthrex Hand and Wrist Products · recruiting
- NCT05145725 — Instrumented POsterolateral Arthrodesis for Adolescent Idiopathic Scoliosis · recruiting
Other Vestre Viken Hospital Trust trials
Trials by the same sponsor.
- NCT07200713 — Effect Study of SMART Treatment for Youth · NA · not yet recruiting
- NCT06906419 — Arthroscopic Trochleaplasty in Chronic Relapsing Patellar Dislocations: A Follow-up Study · enrolling by invitation
- NCT06920654 — Stabilization of the Shoulder Joint Using a Latarjet-like Procedure. · enrolling by invitation
- NCT06738381 — Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease · NA · recruiting
- NCT06912061 — A Needle Technique for Achilles Tendon Lengthening in Pediatric Patients: A Prospective Study on Efficacy, Safety, and F · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06917235 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vestre Viken Hospital Trust
- Last refreshed: 13 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06917235.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing